Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s share price was up 17.6% during trading on Monday . The stock traded as high as C$0.20 and last traded at C$0.20. Approximately 134,500 shares were traded during mid-day trading, a decline of 48% from the average daily volume of 256,409 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Performance
The company has a debt-to-equity ratio of 4.23, a current ratio of 0.10 and a quick ratio of 0.84. The business has a 50 day moving average price of C$0.16 and a 200 day moving average price of C$0.10. The stock has a market capitalization of C$27.27 million, a PE ratio of -16.84 and a beta of 0.32.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- EV Stocks and How to Profit from Them
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- The 3 Best Blue-Chip Stocks to Buy Now
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- How to Most Effectively Use the MarketBeat Earnings Screener
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
